|
⚲
|
| Keyboard |
| Sofinnova Capital IX
✚
|
|
|---|---|
| CIK # | 0001849915 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001849915] | |
| 4 | [0001849915] | |
| SC 13D | [0001849915] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Sofinnova Capital IX | Cincor Pharma Inc | [2023-02-13] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| CinCor Pharma Inc | |
| Sofinnova Capital IX | |
| Sofinnova Partners SAS |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CinCor Pharma Inc CINC
Common Stock
|
2022-08-15 | Buy | 133,333 | $30.00 | 3,999,990 |
|
CinCor Pharma Inc CINC
Common Stock
|
2022-01-11 | Conversion | 3,867,646 | ||
|
CinCor Pharma Inc CINC
Common Stock
|
2022-01-11 | Buy | 220,000 | $16.00 | 3,520,000 |
|
CinCor Pharma Inc CINC
Series B Preferred Stock · derivative
|
2022-01-11 | Conversion | 3,150,000 | $0.00 | |
|
CinCor Pharma Inc CINC
Series A Preferred Stock · derivative
|
2022-01-11 | Conversion | 9,999,999 | $0.00 |